Roche Corleen M. — SEC insider filings

SEC reporting owner CIK 1857905. 12 insider filings on record with FilingPulse; latest filed 2026-11-10.

Transaction summary — filings shown

Covers all 12 filings on record, filed 2021-04-21 to 2026-11-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
CG Oncology, Inc. (CGON)CFO41 leg · 2,000 sh · $38,000—3
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)Chief Financial Officer4——9
Immunome Inc. (IMNM)Chief Financial Officer4——4

Insider filings — Roche Corleen M.

FiledFormIssuerReported transactionsSource
2026-11-104IOVANCE BIOTHERAPEUTICS, INC. (IOVA)Option exercise (M): 12,500 @ $0 · Tax withholding (F): 5,311 @ $8.04 · Option exercise (M): 12,500 (derivative) @ $0EDGAR
2026-08-104IOVANCE BIOTHERAPEUTICS, INC. (IOVA)Option exercise (M): 49,995 @ $0 · Tax withholding (F): 21,238 @ $6.21 · Option exercise (M): 49,995 (derivative) @ $0EDGAR
2026-03-114IOVANCE BIOTHERAPEUTICS, INC. (IOVA)Grant/award (A): 132,200 (derivative) @ $0EDGAR
2025-08-084IOVANCE BIOTHERAPEUTICS, INC. (IOVA)Grant/award (A): 300,000 (derivative) @ $0 · Grant/award (A): 150,000 (derivative) @ $0EDGAR
2025-04-164CG Oncology, Inc. (CGON)Grant/award (A): 143,907 (derivative) @ $0EDGAR
2024-10-084CG Oncology, Inc. (CGON)Grant/award (A): 93,600 (derivative) @ $0EDGAR
2024-01-314CG Oncology, Inc. (CGON)Purchase (P): 2,000 @ $19EDGAR
2024-01-264CG Oncology, Inc. (CGON)Grant/award (A): 492,920 (derivative) @ $0EDGAR
2023-06-124Immunome Inc. (IMNM)Grant/award (A): 58,000 (derivative) @ $0EDGAR
2022-06-214Immunome Inc. (IMNM)Grant/award (A): 70,000 (derivative) @ $0EDGAR
2021-06-014Immunome Inc. (IMNM)Grant/award (A): 16,609 (derivative) @ $0EDGAR
2021-04-214Immunome Inc. (IMNM)Grant/award (A): 125,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-01-21 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1857905 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs